Indonesia is expected to receive drugs for acute kidney injury from Singapore and Australia amid increasing children's deaths from the disease, Health Minister Budi Gunadi Sadikin announced.
As of Saturday, the number of children in Indonesia who died from atypical progressive acute kidney injury has risen to 133, forcing the authorities to temporarily ban all sales and prescription of syrup-based medications nationwide, reports Xinhua news agency.
The needed rare drugs expected to arrive in Indonesia are Fomepizole drug vials, with 10 from Singapore and 16 from Australia, the Minister told reporters here on Sunday.
The Health Ministry had ordered less than 200 vials previously.
Each patient is expected to receive one vial with 1.5 gram or 1.5 ml injection dose.
"We hope the drugs can be distributed immediately to hospitals soon after they arrive here," Sadikin added.
The Minister also expressed appreciation for the assistance from both Singapore and Australia.
The Indonesian government has been working to identify possible causes of the acute kidney injury in the children, who are mostly less than six years old, and preliminary investigation has linked it with pathogens contaminating the syrup medicines taken by them, such as ethylene glycol, diethylene glycol, and ethylene glycol butyl ether.
The Ministry earlier assured that the acute kidney injury cases were not related to Covid-19 vaccines as the jabs are only for people aged six and above in the Southeast Asian country.
Recently, about 70 children in Gambia died from acute kidney injury, which were allegedly related to the diethylene glycol and ethylene glycol content in four Indian-made cough syrups.
But Indonesia's food and drug regulatory agency confirmed these drugs were not registered in the country.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)